Raymond Kelleher
Directeur/Membre du Conseil chez Expansion Therapeutics, Inc.
Provenance du réseau au premier degré de Raymond Kelleher
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Arkuda Therapeutics, Inc.
 Arkuda Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arkuda Therapeutics, Inc. engages in development of medicines to improve the lives of patients with neurological diseases. It leverages insights into progranulin and lysosomal biology to develop medicines to change the trajectory of neurodegenerative disease. The company was founded by Gerhard Koenig and Duane Burnett in 2018 and is headquartered in Cambridge, MA.
11
| Holding Company | Pharmaceuticals: Major | 11 |
ONK Therapeutics Ltd.
 ONK Therapeutics Ltd. BiotechnologyHealth Technology ONK Therapeutics Ltd. develops bio cells for anti cancer therapies. The company was founded by Michael O'Dwyer and Anthony Killarney in 2015 and is headquartered in Galway, Ireland.
10
| Holding Company | Biotechnology | 10 |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.
9
| Holding Company | Biotechnology | 9 |
Garuda Therapeutics, Inc.
 Garuda Therapeutics, Inc. BiotechnologyHealth Technology Garuda Therapeutics, Inc. aims to eliminate the need for donor or patient cells for blood stem cell transplants. The company is based in Natick, MA. The company's platform technology generates off-the-shelf, self-renewing blood stem cells that are HLA-compatible and transgene-free. This technology could potentially provide curative therapies for over 120 diseases. Garuda Therapeutics was founded by Dhvanit Shah, Sean Morrison, and David T. Scadden, with Dhvanit Shah serving as CEO since incorporation.
8
| Holding Company | Biotechnology | 8 |
Expansion Therapeutics, Inc.
 Expansion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Expansion Therapeutics, Inc. manufactures pharmaceutical products. The company is headquartered in Del Mar, CA.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Cormorant Asset Management LLC/Private Equity/
 Cormorant Asset Management LLC/Private Equity/ Investment ManagersFinance Cormorant Asset Management LLC/Private Equity/ (Cormorant Asset Management) is a venture capital subsidiary of Cormorant Asset Management LP founded in 2013 by Bi Hua Chen. The firm is headquartered in Boston, Massachusetts.
4
| Operating Division | Investment Managers | 4 |
BiVACOR, Inc.
 BiVACOR, Inc. Medical SpecialtiesHealth Technology BiVACOR, Inc. develops and manufactures medical device. The firm specializes in rotary blood pumps, biomedical engineering. The company was founded by Daniel Timms in 2008 and is headquartered in Houston, TX.
4
| Holding Company | Medical Specialties | 4 |
GC Therapeutics, Inc.
 GC Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services GC Therapeutics, Inc. is a company based in Cambridge, MA. GC Therapeutics uses synthetic biology to program stem cells into any cell type with efficiency, speed, and scalability. The company has validated cells for many applications and have developed supercells™ by tailoring cells for specific diseases. The company's goal is to bring this breakthrough approach to patients. The company was founded in 2019 by Parastoo Khoshakhlagh, Alex Ng, Cory Smith, and George McDonald Church, with Parastoo Khoshakhlagh as the CEO since 2019.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Raymond Kelleher via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
| Harvard Medical School | College/University | Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
| Yale University | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Graduate Degree | |
| VIGIL NEUROSCIENCE, INC. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
| X4 PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member Founder | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Tech/Sci/R&D Officer Sales & Marketing Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| KYVERNA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Incendia Therapeutics, Inc.
 Incendia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Incendia Therapeutics, Inc. develops a novel class of anti-cancer therapies. The company is based in Boston, MA. The company was founded in 2003 by Laurent Audoly, Colin Glenn Begley, Olga Granaturova, Guy Travis Clifton. Laurent Audoly has been the CEO since 2003. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| Stanford University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| SCPHARMACEUTICALS INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Operating Officer | |
| PACIRA BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ARRIVENT BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CINCOR PHARMA, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Boston College | College/University | Graduate Degree Undergraduate Degree | |
| KARA THER | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Electra Therapeutics, Inc.
 Electra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Electra Therapeutics, Inc. is a clinical stage biotechnology company that develops therapies for the treatment of immunological diseases and cancer. The company is based in San Francisco, CA. The company's lead product candidate, ela026, is a monoclonal antibody that targets sirp on the cell surface of and t cells, and precisely depletes pathological immune cells. Electra currently has one program in clinical development and additional preclinical programs. The company was founded by Adam Rosenthal, who has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| C4 THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal Chief Executive Officer | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor | |
Totus Medicines, Inc.
 Totus Medicines, Inc. Pharmaceuticals: MajorHealth Technology Totus Medicines, Inc. manufactures drug products. The company is based in Cambridge, MA. The company was founded by Neil Dhawan, Jason Pontin. Neil Dhawan has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Oxford | College/University | Doctorate Degree Doctorate Degree | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| TURG POIN | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Council on Foreign Relations, Inc.
 Council on Foreign Relations, Inc. Investment Trusts/Mutual FundsMiscellaneous Council on Foreign Relations, Inc. provides and disseminates ideas on foreign policies to individuals, corporate members, journalists and policy makers. It operates a forum for government officials, students and other interested parties to study and discuss world issues and impact on American foreign policies. The company publishes Foreign Affairs, a magazine that comes out six times a year, along with books and studies by its own scholars. Council on Foreign Relations was founded in 1921 and is headquartered in New York City, NY. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal | |
| PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
Star Therapeutics, Inc.
 Star Therapeutics, Inc. BiotechnologyHealth Technology Star Therapeutics, Inc. is an American company that aims to develop life-changing therapies for rare diseases. The company's mission is to help millions of patients in urgent need. The company was founded by Adam Rosenthal, who has been the CEO since incorporation. | Biotechnology | Director/Board Member Director/Board Member | |
HotSpot Therapeutics, Inc.
 HotSpot Therapeutics, Inc. BiotechnologyHealth Technology HotSpot Therapeutics, Inc. develops new allosteric therapies with the ability to treat disease. The company was founded by Jonathan Montagu and Geraldine Harriman and is headquartered in Boston, MA. | Biotechnology | Chairman Director/Board Member | |
| BIOCRYST PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blossomhill Therapeutics, Inc. is a small molecule drug discovery and development company that focuses on unmet medical needs in oncology and autoimmune disorders. The company is based in San Diego, CA. Dr. Cui is the lead inventor of multiple oncology medicines and clinical compounds, including crizotinib, lorlatinib, repotrectinib (TPX-0005), TPX-0022, TPX-0046, and TPX-0131. The company was founded by J. Jean Cui, Ph.D., a renowned drug design and development scientist, and Y. Peter Li, Ph.D., M.B.A., a biotech veteran. Jing Rong Cui has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Private Equity Investor Corporate Officer/Principal | |
| CIDARA THERAPEUTICS, INC. | Pharmaceuticals: Other | Chairman Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| TESARO INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ARMO BIOSCIENCES INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Avila Therapeutics, Inc.
 Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in Summit, NJ. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Private Equity Investor Corporate Officer/Principal | |
Terremoto Biosciences, Inc.
 Terremoto Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Terremoto Biosciences, Inc. is a drug discovery and development company that creates highly targeted, small molecule medicines with unmatched selectivity, potency, and efficacy to deliver superior therapeutic benefit to patients. The company is based in San Francisco, CA. Terremoto is supported by leading investors, including OrbiMed, Third Rock Ventures, EcoR1 Capital, Novo Holdings, and Cormorant Capital. The company aims to expand the universe of drug targets and improve existing medicines by unleashing the power of covalent chemistry. Terremoto was founded by Peter A. Thompson and Matthew P. Jacobson, and Peter A. Thompson has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| KYMERA THERAPEUTICS, INC. | Biotechnology | Founder Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 47 |
| Irlande | 2 |
| Royaume-Uni | 2 |
| Mexique | 2 |
Sectorielle
| Health Technology | 35 |
| Consumer Services | 10 |
| Finance | 4 |
| Commercial Services | 3 |
| Miscellaneous | 2 |
Opérationnelle
| Director/Board Member | 372 |
| Independent Dir/Board Member | 103 |
| Corporate Officer/Principal | 102 |
| Chairman | 50 |
| Chief Executive Officer | 45 |
Relations les plus connectées
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| James Healy | 50 |
| Bruce Booth | 40 |
| Beth Seidenberg | 39 |
| Scott Rocklage | 32 |
| Bihua Chen | 32 |
| Pascale Witz | 31 |
| Henry Skinner | 29 |
| Eric Aguiar | 29 |
| Andrew Phillips | 23 |
| Rahul Singhvi | 22 |
| Shaan Gandhi | 22 |
| William Cohn | 19 |
| Jeffrey Tong | 16 |
| Gary Bridger | 16 |
- Bourse
- Insiders
- Raymond Kelleher
- Connexions Sociétés